Showing results (31-40 of 1,173) with videos related to
Sort By:
Pageof 118
Molecular Cancer Therapeutics|September 13, 2019
Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer CellsPing Fan, Doris R Siwak, Balkees Abderrahman, et al.Cell Death Discovery|March 14, 2018
Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cellsPing Fan, Amit K Tyagi, Fadeke A Agboke, et al.Molecular Pharmacology|May 5, 2020
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer CellsPhilipp Y Maximov, Balkees Abderrahman, Yousef M Hawsawi, et al.Breast (Edinburgh, Scotland)|October 22, 2011
The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunitiesV Craig Jordan, Ifeyinwa Obiorah, Ping Fan, et al.Cancer Cell|June 28, 2002
The secrets of selective estrogen receptor modulation: cell-specific coregulationV Craig JordanThe International Journal of Developmental Biology|December 14, 2011
Four decades of discovery in breast cancer research and treatment--an interview with V. Craig Jordan. Interview by Marc PoirotV Craig JordanDrug Metabolism Reviews|May 11, 2006
Activated estrogens and antiestrogens: a 30-year journey with David KupferV Craig JordanEuropean Journal of Cancer (Oxford, England : 1990)|October 27, 2006
Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trialV Craig JordanJournal of the National Cancer Institute|March 8, 2007
SERMs: meeting the promise of multifunctional medicinesV Craig JordanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders ArriveV Craig JordanPageof 118